JP2004517081A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004517081A5 JP2004517081A5 JP2002546529A JP2002546529A JP2004517081A5 JP 2004517081 A5 JP2004517081 A5 JP 2004517081A5 JP 2002546529 A JP2002546529 A JP 2002546529A JP 2002546529 A JP2002546529 A JP 2002546529A JP 2004517081 A5 JP2004517081 A5 JP 2004517081A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- treatment
- urinary incontinence
- combination
- receptor agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000018 receptor agonist Substances 0.000 claims 7
- 229940044601 receptor agonist Drugs 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 206010046543 Urinary incontinence Diseases 0.000 claims 5
- 206010037211 Psychomotor hyperactivity Diseases 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000000969 carrier Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- DFMQXSQHKBNHNU-UHFFFAOYSA-N n-[3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]phenyl]methanesulfonamide;hydrochloride Chemical compound Cl.CS(=O)(=O)NC1=CC=CC(CCN2CCN(CC2)C=2C=C(C=CC=2)C(F)(F)F)=C1 DFMQXSQHKBNHNU-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25020300P | 2000-11-29 | 2000-11-29 | |
| PCT/US2001/042949 WO2002044159A2 (en) | 2000-11-29 | 2001-11-16 | 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004517081A JP2004517081A (ja) | 2004-06-10 |
| JP2004517081A5 true JP2004517081A5 (enExample) | 2005-11-17 |
Family
ID=22946725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002546529A Pending JP2004517081A (ja) | 2000-11-29 | 2001-11-16 | １−（２−ｍ−メタンスルホンアミドフェニルエチル）−４−（ｍ−トリフルオロメチルフェニル）ピペラジンならびにその医薬的に許容しうる塩および溶媒和物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6864262B2 (enExample) |
| EP (1) | EP1341777B1 (enExample) |
| JP (1) | JP2004517081A (enExample) |
| AT (1) | ATE374192T1 (enExample) |
| AU (1) | AU2002230411A1 (enExample) |
| CA (1) | CA2427098A1 (enExample) |
| DE (1) | DE60130677T2 (enExample) |
| ES (1) | ES2292636T3 (enExample) |
| WO (1) | WO2002044159A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9186359B2 (en) * | 2010-10-15 | 2015-11-17 | Contera Pharma Aps | Combinations of serotonin receptor agonists for treatment of movement disorders |
| PT2838517T (pt) | 2012-04-18 | 2018-01-04 | Contera Pharma Aps | Formulação farmacêutica disponível sob forma oral adequada para a melhoria da gestão dos distúrbios da mobilidade |
| JP7227896B2 (ja) | 2016-07-11 | 2023-02-22 | コンテラ ファーマ エー／エス | 朝の無動状態を治療するための拍動性薬物送達系 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1300728A (enExample) * | 1959-10-20 | 1962-07-02 | ||
| BE755015A (fr) * | 1969-08-20 | 1971-02-01 | Byk Gulden Lomberg Chem Fab | Piperazinyl-alcoylamino-uraciles substitues par un groupe aryle, leurs ethers et thioethers, ainsi que leur procede de preparation |
| BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
| FR2362628A1 (fr) * | 1976-08-26 | 1978-03-24 | Roussel Uclaf | Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments |
| US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
| DE3321969A1 (de) * | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| NZ209876A (en) * | 1983-10-17 | 1988-03-30 | Duphar Int Res | Piperazines and pharmaceutical compositions |
| DK172696B1 (da) * | 1987-08-13 | 1999-05-31 | Glaxo Group Ltd | Indolderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende forbindelserne |
| ATE139230T1 (de) | 1988-12-15 | 1996-06-15 | Abbott Lab | 5-ht-selektive mittel |
| DE69132691T2 (de) * | 1990-06-07 | 2002-06-20 | Astrazeneca Ab, Soedertaelje | Indolderivate als 5-HT1-like Agonisten |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
| ATE204262T1 (de) * | 1991-09-18 | 2001-09-15 | Glaxo Group Ltd | Benzanilidderivate als 5-ht1d-antagonisten |
| CA2084531A1 (en) * | 1991-12-19 | 1993-06-20 | David W. Smith | Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines |
| SI9300097B (en) * | 1992-02-27 | 2001-12-31 | Janssen Pharmaceutica Nv | (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines |
| US5521188A (en) * | 1993-09-16 | 1996-05-28 | Bristol-Myers Squibb Company | Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines |
| JPH09506101A (ja) * | 1993-12-07 | 1997-06-17 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ５ｈｔ１ｄ拮抗薬として有用な複素環式ビフェニリルアミド類 |
| SE9504661D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| KR100508626B1 (ko) * | 1997-06-27 | 2005-08-17 | 니폰 가야꾸 가부시끼가이샤 | 빈뇨·요실금 치료·예방제 및 트로폰 유도체 |
| JP3441636B2 (ja) | 1997-11-21 | 2003-09-02 | 株式会社エヌ・ティ・ティ・ドコモ | チャネル推定値を求める装置および方法、受信装置ならびに伝送システム |
-
2001
- 2001-11-16 EP EP01990644A patent/EP1341777B1/en not_active Expired - Lifetime
- 2001-11-16 AT AT01990644T patent/ATE374192T1/de not_active IP Right Cessation
- 2001-11-16 ES ES01990644T patent/ES2292636T3/es not_active Expired - Lifetime
- 2001-11-16 CA CA002427098A patent/CA2427098A1/en not_active Abandoned
- 2001-11-16 US US10/432,413 patent/US6864262B2/en not_active Expired - Fee Related
- 2001-11-16 DE DE60130677T patent/DE60130677T2/de not_active Expired - Fee Related
- 2001-11-16 JP JP2002546529A patent/JP2004517081A/ja active Pending
- 2001-11-16 WO PCT/US2001/042949 patent/WO2002044159A2/en not_active Ceased
- 2001-11-16 AU AU2002230411A patent/AU2002230411A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR20C1018I1 (fr) | Composition pharmaceutique comprenant du glycopyrrolate et un agoniste du récepteur beta2 adrénergique | |
| JP2004532209A5 (enExample) | ||
| GEP20094605B (en) | Pyrazole derivatives, compositions containing such compounds and methods of use thereof | |
| DE60039508D1 (de) | Methoden zur behandlung der essstörungen | |
| RU93043528A (ru) | Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения | |
| WO2005051946A3 (en) | Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity | |
| SE0300010D0 (sv) | Novel Compounds | |
| JP2005531488A5 (enExample) | ||
| EP2036902A3 (en) | Urea compounds active as vanilloid receptor antagonist for the treatment of pain | |
| KR950016746A (ko) | 비-펩티드 타키키닌 수용체 길항물질 | |
| JP2003012668A5 (enExample) | ||
| AU2003250471A8 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
| HRP20080446T3 (en) | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine | |
| JP2004517081A5 (enExample) | ||
| WO2005118579A3 (en) | Thiazole derivatives as chemokine receptor antagonists | |
| JP2007533655A5 (enExample) | ||
| ATE380189T1 (de) | 2-amino-5-benzoylthiazol npy-antagonisten | |
| KR950016741A (ko) | 체중 증가를 억제하거나 또는 체중 감소를 유도하는 방법 | |
| JP2005513103A5 (enExample) | ||
| RU2003113145A (ru) | Замещенные 5r1, 6r2-1, 3,4-тиадиазин-2, амины и содержащие их фармацевтические композиции в качестве фармакологически активных средств, обладающих антикоагулятным и антиагрегатным действием | |
| RU2003114440A (ru) | Мезилат 8-{4-[3-фтор-1н-индол-3-ил) пропил] пиперазин-1 -ил} -2-метил-4н-бензол[1,4] оксазин-3-он с высоким сродством к допаминовому рецекптору d2 и сайту повторного поглощения серотонина | |
| JP2007506780A5 (enExample) | ||
| AR048948A1 (es) | Una composicion farmaceutica antimicobacteriana | |
| CO5261525A1 (es) | Forma poliformica de un antagonista de los receptores de las taquiquininas . | |
| JP2004508372A5 (enExample) |